Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

Leveraging Pathophysiology and Context-of-Use to Identify MASH Clinical Trial Biomarkers

Presentation | Video

Tagged in:

Bioanalysisbioanalyticalbiomarkersmetabolic disease